Testosterone May Hold Therapeutic Promise for the Treatment of Ischemic Stroke in Aging: A Closer Look at Laboratory Findings

Overview

Journal Adv Pharm Bull

Date 2019 Apr 24

PMID 31011557

Citations 2

Authors

Fereshteh Farajdokht

Mehdi Farhoudi

Alireza Majdi

Masumeh Zamanlu

Saeed Sadigh-Eteghad

Shabnam Vahedi

Javad Mahmoudi

Affiliations

Soon will be listed here.

Abstract

Male sex is more prone to cerebrovascular disorders, yet the exact role of androgens in cerebral ischemia remains unclear. Here we reviewed current understanding of testosterone (TES) neuroprotective activity against ischemic stroke and mechanisms underlying these effects in aging. TES may exert a neuroprotective effect in aging through pathways including inhibition of oxidant molecules production, enhancing the enzymatic antioxidant capacity of the brain and modulation of apoptotic cell death. Given this, a better understanding of the neuroprotective roles of TES may propose an effective therapeutic strategy to improve the quality of life and decrease androgen-related cerebrovascular problems in the aging men.

Citing Articles

Fast-spiking parvalbumin-positive interneurons: new perspectives of treatment and future challenges in dementia.

Zhang X, Wu M, Cheng L, Cao W, Liu Z, Yang S Mol Psychiatry. 2024; 30(2):693-704.

PMID: 39695324 DOI: 10.1038/s41380-024-02756-6.

Sex differences in the response to oxidative and proteolytic stress.

Tower J, Pomatto L, Davies K Redox Biol. 2020; 31:101488.

PMID: 32201219 PMC: 7212483. DOI: 10.1016/j.redox.2020.101488.

References

Chen H, Zirkin B . Long-term suppression of Leydig cell steroidogenesis prevents Leydig cell aging. Proc Natl Acad Sci U S A. 1999; 96(26):14877-81. PMC: 24741. DOI: 10.1073/pnas.96.26.14877. View

Stellato R, Feldman H, Hamdy O, Horton E, McKinlay J . Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000; 23(4):490-4. DOI: 10.2337/diacare.23.4.490. View

Dringen R . Metabolism and functions of glutathione in brain. Prog Neurobiol. 2000; 62(6):649-71. DOI: 10.1016/s0301-0082(99)00060-x. View

El Kossi M, Zakhary M . Oxidative stress in the context of acute cerebrovascular stroke. Stroke. 2000; 31(8):1889-92. DOI: 10.1161/01.str.31.8.1889. View

Zirkin B, Chen H . Regulation of Leydig cell steroidogenic function during aging. Biol Reprod. 2000; 63(4):977-81. DOI: 10.1095/biolreprod63.4.977. View

Vlasova I . The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity. Platelets. 2000; 11(7):406-14. DOI: 10.1080/09537100020000157. View

Luo L, Chen H, Zirkin B . Leydig cell aging: steroidogenic acute regulatory protein (StAR) and cholesterol side-chain cleavage enzyme. J Androl. 2001; 22(1):149-56. View

Karbownik M, Garcia J, Lewinski A, Reiter R . Carcinogen-induced, free radical-mediated reduction in microsomal membrane fluidity: reversal by indole-3-propionic acid. J Bioenerg Biomembr. 2001; 33(1):73-8. DOI: 10.1023/a:1005628808688. View

Matsumoto A . Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci. 2002; 57(2):M76-99. DOI: 10.1093/gerona/57.2.m76. View

10.

Feldman H, Longcope C, Derby C, Johannes C, Araujo A, Coviello A . Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002; 87(2):589-98. DOI: 10.1210/jcem.87.2.8201. View

11.

Chen H, Hardy M, Zirkin B . Age-related decreases in Leydig cell testosterone production are not restored by exposure to LH in vitro. Endocrinology. 2002; 143(5):1637-42. DOI: 10.1210/endo.143.5.8802. View

12.

Culty M, Luo L, Yao Z, Chen H, Papadopoulos V, Zirkin B . Cholesterol transport, peripheral benzodiazepine receptor, and steroidogenesis in aging Leydig cells. J Androl. 2002; 23(3):439-47. View

13.

Maeda M, Furuichi Y, Ueyama N, Moriguchi A, Satoh N, Matsuoka N . A combined treatment with tacrolimus (FK506) and recombinant tissue plasminogen activator for thrombotic focal cerebral ischemia in rats: increased neuroprotective efficacy and extended therapeutic time window. J Cereb Blood Flow Metab. 2002; 22(10):1205-11. DOI: 10.1097/01.wcb.0000037993.34930.72. View

14.

Gu F, Hata R, Toku K, Yang L, Ma Y, Maeda N . Testosterone up-regulates aquaporin-4 expression in cultured astrocytes. J Neurosci Res. 2003; 72(6):709-15. DOI: 10.1002/jnr.10603. View

15.

Chen H, Irizarry R, Luo L, Zirkin B . Leydig cell gene expression: effects of age and caloric restriction. Exp Gerontol. 2004; 39(1):31-43. DOI: 10.1016/j.exger.2003.09.021. View

16.

Malkin C, Pugh P, Jones R, Kapoor D, Channer K, Jones T . The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004; 89(7):3313-8. DOI: 10.1210/jc.2003-031069. View

17.

Bialek M, Zaremba P, Borowicz K, Czuczwar S . Neuroprotective role of testosterone in the nervous system. Pol J Pharmacol. 2004; 56(5):509-18. View

18.

Luo L, Chen H, Zirkin B . Temporal relationships among testosterone production, steroidogenic acute regulatory protein (StAR), and P450 side-chain cleavage enzyme (P450scc) during Leydig cell aging. J Androl. 2004; 26(1):25-31. View

19.

Pan Y, Zhang H, Acharya A, Patrick P, Oliver D, Morley J . Effect of testosterone on functional recovery in a castrate male rat stroke model. Brain Res. 2005; 1043(1-2):195-204. DOI: 10.1016/j.brainres.2005.02.078. View

20.

Jones R, Nettleship J, Kapoor D, Jones H, Channer K . Testosterone and atherosclerosis in aging men: purported association and clinical implications. Am J Cardiovasc Drugs. 2005; 5(3):141-54. DOI: 10.2165/00129784-200505030-00001. View